Literature DB >> 7930484

Interleukin-6: an early marker of bacterial infection in decompensated cirrhosis.

O Le Moine1, J Devière, J M Devaster, A Crusiaux, F Durand, J Bernuau, M Goldman, J P Benhamou.   

Abstract

Fifty-seven patients with decompensated cirrhosis were studied prospectively to assess the sensitivity and specificity of early clinical or biological signs of bacterial infection. Among them, 19 had proven infection on admission (7 spontaneous bacterial peritonitis, 5 bacteraemia, 3 urinary tract infections, 2 pneumonia, 1 dental abscess and 1 cholangitis). Fever, polymorphonuclear cell count, fibrinogen and C-reactive protein levels were found to be of little or no help in diagnosing bacterial infection on admission. Interleukin-6 plasma levels were, however, significantly different between infected (median: 1386 pg/ml, range: 237-20,000) and non-infected patients (median: 34 pg/ml, range: 0-4500, p < 0.00001). Levels above 200 pg/ml were always found in infected patients, giving a sensitivity of 100% and a specificity of 74%. C-reactive protein correlated weakly with interleukin-6 levels, indicating a defective acute-phase response in cirrhosis. Tumor necrosis factor alpha plasma levels were less sensitive (95%) and specific (68%) for the diagnosis of bacterial infection at a threshold of 50 pg/ml, but were more closely related to a poor patient outcome. In decompensated cirrhosis, interleukin-6 plasma levels on admission provided the most sensitive and specific tool for the diagnosis of bacterial infection.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7930484     DOI: 10.1016/s0168-8278(05)80155-2

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  18 in total

1.  Circulating endothelial progenitor cells are not affected by acute systemic inflammation.

Authors:  Gareth J Padfield; Olga Tura; Marlieke L A Haeck; Abigail Short; Elizabeth Freyer; G Robin Barclay; David E Newby; Nicholas L Mills
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-04-09       Impact factor: 4.733

2.  Cytotoxic effects of Kingella kingae outer membrane vesicles on human cells.

Authors:  R Maldonado; R Wei; S C Kachlany; M Kazi; N V Balashova
Journal:  Microb Pathog       Date:  2011-04-02       Impact factor: 3.738

3.  Expression of proinflammatory cytokines and their inhibitors during the course of spontaneous bacterial peritonitis.

Authors:  C Rodríguez-Ramos; F Galan; F Díaz; J Elvira; L Martín-Herrera; J A Girón-González
Journal:  Dig Dis Sci       Date:  2001-08       Impact factor: 3.199

4.  Neuropsychiatric evaluation of patients with brucellosis.

Authors:  Ghaydaa A Shehata; Laila Abdel-Baky; Heba Rashed; Hussein Elamin
Journal:  J Neurovirol       Date:  2010-02       Impact factor: 2.643

5.  Trichostatin A Protects Against Experimental Acute-on-Chronic Liver Failure in Rats Through Regulating the Acetylation of Nuclear Factor-κB.

Authors:  Qian Zhang; Fan Yang; Xun Li; Lu-wen Wang; Xiao-gang Chu; Hong Zhang; Zuo-jiong Gong
Journal:  Inflammation       Date:  2015       Impact factor: 4.092

Review 6.  Beyond Metabolism: Role of the Immune System in Hepatic Toxicity.

Authors:  Kenneth L Hastings; Martin D Green; Bin Gao; Patricia E Ganey; Robert A Roth; Gary R Burleson
Journal:  Int J Toxicol       Date:  2020 Mar/Apr       Impact factor: 2.032

7.  Early identification of infectious complications in bariatric surgery by the determination of peritoneal and systemic cytokines.

Authors:  Wilson Salgado; Fernando de Queiroz Cunha; José Sebastião dos Santos; Carla Barbosa Nonino-Borges; Ajith Kumar Sankarankutty; Orlando de Castro E Silva; Reginaldo Ceneviva
Journal:  Obes Surg       Date:  2009-05-12       Impact factor: 4.129

8.  An inhibitor of interleukin-6 trans-signalling, sgp130, contributes to impaired acute phase response in human chronic liver disease.

Authors:  A Lemmers; T Gustot; A Durnez; S Evrard; C Moreno; E Quertinmont; V Vercruysse; P Demetter; D Franchimont; O Le Moine; A Geerts; J Devière
Journal:  Clin Exp Immunol       Date:  2009-06       Impact factor: 4.330

9.  Usefulness of C-reactive protein for evaluating clinical outcomes in cirrhotic patients with bacteremia.

Authors:  Young Eun Ha; Cheol-In Kang; Eun-Jeong Joo; Mi-Kyong Joung; Doo Ryeon Chung; Kyong Ran Peck; Nam Yong Lee; Jae-Hoon Song
Journal:  Korean J Intern Med       Date:  2011-06-01       Impact factor: 2.884

10.  Synthesis of acute phase proteins in rats with cirrhosis exposed to lipopolysaccharide.

Authors:  Susanne Schouw Nielsen; Thorbjørn Grøfte; Niels Tygstrup; Hendrik Vilstrup
Journal:  Comp Hepatol       Date:  2006-09-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.